Centerbridge exits GoHealth as Chapter 11 cancels equity

GoHealth, Inc. underwent a prepackaged Chapter 11 plan of reorganization that became effective on July 21, 2026.

Rhea-AI Filing Summary

GoHealth, Inc. underwent a prepackaged Chapter 11 plan of reorganization that became effective on July 21, 2026. Under this plan, all outstanding shares of Class A common stock, restricted stock, restricted stock units, and any other equity rights were cancelled and discharged and are of no force and effect. Holders of these interests, including the Centerbridge-affiliated reporting persons, received their pro rata share of an approximately $10.3 million cash equity recovery pool. Following this restructuring, the reporting persons now report 0 shares beneficially owned and 0% of the class, reflecting a complete exit from GoHealth’s equity.

Positive

• None.

Negative

• All GoHealth Class A common stock and equity rights cancelled in Chapter 11, with holders receiving only a pro rata share of an approximately $10.3 million cash equity recovery pool, indicating a substantial loss of prior equity value.

Key Figures

Cash equity recovery pool: $10.3 million Beneficial ownership after plan: 0.00 shares Percent of class after plan: 0 % +2 more

5 metrics

Cash equity recovery pool $10.3 million Pro rata cash recovery to holders of GoHealth equity interests under the Chapter 11 plan

Beneficial ownership after plan 0.00 shares Each reporting person’s Class A common stock beneficial ownership following plan effectiveness

Percent of class after plan 0 % Class A common stock percentage held by each reporting person after reorganization

Chapter 11 filing date June 7, 2026 Date voluntary Chapter 11 petitions were filed in the Bankruptcy Court

Plan Effective Date July 21, 2026 Date the prepackaged Chapter 11 plan became effective and equity was cancelled

Key Terms

prepackaged Chapter 11 plan of reorganization, Effective Date, Allowed GoHealth Holding Interests, cash equity recovery pool

4 terms

prepackaged Chapter 11 plan of reorganization regulatory

"filed voluntary petitions ... to implement a prepackaged Chapter 11 plan of reorganization"

Effective Date regulatory

"The Plan became effective on July 21, 2026 (the "Effective Date")."

The effective date is the specific calendar day when a contract, regulatory action, corporate change, or financial disclosure officially begins to apply and take legal or operational effect. For investors, it marks the moment rules, obligations, ownership, pricing, or reporting change—similar to the exact minute a light switch is flipped—so it determines when rights, liabilities, or market impacts start and which periods or transactions are affected.

Allowed GoHealth Holding Interests regulatory

"holders of Class A common stock and other Allowed GoHealth Holding Interests ... received"

cash equity recovery pool financial

"received their pro rata share of an approximately $10.3 million cash equity recovery pool."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the GOCOQ Schedule 13D/A amendment disclose about Centerbridge’s ownership?

It disclosed that Centerbridge-affiliated reporting persons now beneficially own 0 shares and 0% of GoHealth’s Class A common stock. This followed a Chapter 11 plan that cancelled all existing equity and replaced it with a limited cash recovery.

How did GoHealth’s Chapter 11 plan affect GOCOQ common shareholders?

The plan cancelled and discharged all Class A common stock and other equity rights as of July 21, 2026. Former holders instead received a pro rata share of an approximately $10.3 million cash equity recovery pool, significantly reducing their economic stake.

What is the $10.3 million cash equity recovery pool mentioned for GOCOQ?

It is an approximately $10.3 million pool of cash distributed pro rata to holders of GoHealth equity interests. Those interests, including Class A common stock and restricted units, were cancelled under the Chapter 11 plan, and this pool represents the cash recovery in place of prior equity.

When did GoHealth’s Chapter 11 reorganization become effective for GOCOQ investors?

The prepackaged Chapter 11 plan became effective on July 21, 2026, defined as the Effective Date. On that date, all outstanding GoHealth equity interests were cancelled, and eligible holders received their share of the $10.3 million cash equity recovery pool.

Did the GOCOQ reporting persons trade shares shortly before the Chapter 11 plan?

The amendment states that, apart from the plan-related effects, no reporting person or listed individual effected any transaction in GoHealth Class A common stock during the past sixty days. Their ownership changed due to equity cancellation, not open-market trading.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 09:46 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)

GoHealth, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.0001 per share

(Title of Class of Securities)

38046W105

(CUSIP Number)

Susanne V. Clark
c/o Centerbridge Partners, L.P., 375 Park Avenue, 13th Floor
New York, NY, 10152
(212) 672-5000

Susanne V. Clark
375 Park Avenue, 13th Floor,
New York, NY, 10152
(212) 672-5000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

07/21/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CCP III Cayman GP Ltd.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Holdings C, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

Centerbridge Associates III, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CCP III AIV VII Holdings, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Co-Invest Holdings, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Lower Holdings GP A, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Lower Holdings A, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

Blizzard Aggregator, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Lower Holdings GP B, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

CB Blizzard Lower Holdings B, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP Number(s): 38046W105

1

Name of reporting person

Jeffrey H. Aronson

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Common Stock, par value $0.0001 per share
(b)	Name of Issuer: GoHealth, Inc.
(c)	Address of Issuer's Principal Executive Offices: 222 W MERCHANDISE MART PLAZA, SUITE 1750, CHICAGO, ILLINOIS , 60654.
Item 1 Comment: This Amendment No. 6 to Schedule 13D ("Amendment No. 6") amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission on November 25, 2022 (as amended to date, the "Schedule 13D"), relating to the shares of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), of GoHealth, Inc., a Delaware corporation (the "Issuer"). Capitalized terms used herein without definition shall have the meanings set forth in the Schedule 13D.
Item 4.	Purpose of Transaction
	Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On June 7, 2026, GoHealth, Inc. (the "Issuer"), GoHealth Holdings, LLC and certain of their direct and indirect subsidiaries filed voluntary petitions commencing cases under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware to implement a prepackaged Chapter 11 plan of reorganization (the "Plan"). The Plan became effective on July 21, 2026 (the "Effective Date"). Pursuant to the Plan, on the Effective Date, all of the Issuer's Class A common stock together with any shares of restricted stock, restricted stock units, or any other right to receive equity in the Issuer, in each case, outstanding immediately prior to the Effective Date, were cancelled, discharged and are of no force and effect and holders of Class A common stock and other Allowed GoHealth Holding Interests (as defined in the Plan), including the Reporting Persons, received their pro rata share of an approximately $10.3 million cash equity recovery pool. As a result, the Reporting Persons no longer beneficially own any securities or any other right to receive equity in the Issuer.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows: (a) - (b) Pursuant to the Plan, which became effective on July 21, 2026, all outstanding shares of Class A Common Stock together with any shares of restricted stock, restricted stock units, or any other right to receive equity in the Issuer, in each case, outstanding immediately prior to the Effective Date, were cancelled. As of the date of this Amendment, the Reporting Persons do not beneficially own any shares of Class A Common Stock or any shares of restricted stock, restricted stock units, or any other right to receive equity in the Issuer.
(b)	See Item 5(a) above.
(c)	Except as set forth above, none of the Reporting Persons nor, to the best knowledge of the Reporting Persons, any of the other individuals named in Item 2, has effected any transaction in shares of Class A Common Stock during the past sixty days.
(d)	None.
(e)	July 21, 2026
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Item 6 of the Schedule 13D is hereby amended and supplemented as follows The information set forth in Item 4 of the Schedule 13D is hereby incorporated by reference into this Item 6.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CCP III Cayman GP Ltd.

Signature:	/s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Holdings C, L.P.

Signature:	By: CCP III Cayman GP Ltd., its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

Centerbridge Associates III, L.P.

Signature:	By: CCP III Cayman GP Ltd., its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CCP III AIV VII Holdings, L.P.

Signature:	By: Centerbridge Associates III, L.P., its general partner.By: CCP III Cayman GP Ltd., its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Co-Invest Holdings, L.P.

Signature:	By: Centerbridge Associates III, L.P., its general partner,By: CCP III Cayman GP Ltd., its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Lower Holdings GP A, LLC

Signature:	/s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Lower Holdings A, L.P.

Signature:	By: CB Blizzard Lower Holdings GP A, LLC, its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

Blizzard Aggregator, LLC

Signature:	By: CCP III Cayman GP Ltd., its sole manager, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Lower Holdings GP B, LLC

Signature:	/s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

CB Blizzard Lower Holdings B, L.P.

Signature:	By: CB Blizzard Lower Holdings GP B, LLC, its general partner, /s/ Susanne V. Clark
Name/Title:	Susanne V. Clark/Authorized Signatory
Date:	08/17/2026

Jeffrey H. Aronson

Signature:	/s/ Jeffrey H. Aronson
Name/Title:	Jeffrey H. Aronson
Date:	08/17/2026